Compare S&P500 ETF (SPY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

S&P500 ETFTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

S&P500 ETF vs State Street SPDR S&P Biotech ETF — how do they compare? S&P500 ETF trades at $748.05, while State Street SPDR S&P Biotech ETF trades at $154.46. Which is the better fit depends on your goals.

	SPY	XBI
52-Week High	$759.55	$164.28
52-Week Low	$621.75	$85.16
Sector	—	Broad Market / Factor

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 6 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 13 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.